Ignite Creation Date:
2025-12-25 @ 12:19 AM
Ignite Modification Date:
2026-04-13 @ 9:58 PM
Study NCT ID:
NCT03066258
Status:
COMPLETED
Last Update Posted:
2023-05-16
First Post:
2017-02-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Tolerability of RGX-314 (Investigational Product) Gene Therapy for Neovascular AMD Trial
Sponsor:
REGENXBIO Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-03-29
Start Date Type:
ACTUAL
Primary Completion Date:
2019-11-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-06-17
Completion Date Type:
ACTUAL
First Submit Date:
2017-02-17
First Submit QC Date:
None
Study First Post Date:
2017-02-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-02-13
Results First Submit QC Date:
None
Results First Post Date:
2023-05-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-12
Last Update Post Date:
2023-05-16
Last Update Post Date Type:
ACTUAL